
### [MONDO:0017254](http://purl.obolibrary.org/obo/MONDO_0017254)
**Label:** posterior uveitis (disease)

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0017257](http://purl.obolibrary.org/obo/MONDO_0017257) (idiopathic posterior uveitis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0017212](http://purl.obolibrary.org/obo/MONDO_0017212) (paraneoplastic uveitis), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0018152](http://purl.obolibrary.org/obo/MONDO_0018152) (serpiginous choroiditis), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0011599](http://purl.obolibrary.org/obo/MONDO_0011599) (birdshot chorioretinopathy), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0017209](http://purl.obolibrary.org/obo/MONDO_0017209) (infectious posterior uveitis), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), 

**Corr. equiv. classes:** [OMIM:109650](http://purl.obolibrary.org/obo/OMIM_109650), [Orphanet:179](http://www.orpha.net/ORDO/Orphanet_179), [OMIM:306400](http://purl.obolibrary.org/obo/OMIM_306400), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [OMIM:605808](http://purl.obolibrary.org/obo/OMIM_605808), [OMIM:138990](http://purl.obolibrary.org/obo/OMIM_138990), [Orphanet:279919](http://www.orpha.net/ORDO/Orphanet_279919), [Orphanet:280917](http://www.orpha.net/ORDO/Orphanet_280917), [Orphanet:279928](http://www.orpha.net/ORDO/Orphanet_279928), [OMIM:613960](http://purl.obolibrary.org/obo/OMIM_613960), [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [OMIM:233710](http://purl.obolibrary.org/obo/OMIM_233710), [OMIM:233700](http://purl.obolibrary.org/obo/OMIM_233700), [Orphanet:35686](http://www.orpha.net/ORDO/Orphanet_35686), [Orphanet:90061](http://www.orpha.net/ORDO/Orphanet_90061), [Orphanet:280930](http://www.orpha.net/ORDO/Orphanet_280930), [OMIM:233690](http://purl.obolibrary.org/obo/OMIM_233690), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [OMIM:609464](http://purl.obolibrary.org/obo/OMIM_609464), [Orphanet:117](http://www.orpha.net/ORDO/Orphanet_117), [OMIM:233670](http://purl.obolibrary.org/obo/OMIM_233670), 

**Class expressions from DL-Learner:**

- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) 40.43%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 39.77%
- [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) 37.27%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) 36.61%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0011947](http://purl.obolibrary.org/obo/HP_0011947) (Respiratory tract infection) 36.19%
- [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 35.63%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) 35.40%
- [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes) 32.66%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 32.39%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 32.34%
- Thing 32.33%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 32.33%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 28.25%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 24.04%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 23.25%


